Danaher Co. (NYSE:DHR) Holdings Decreased by Fiera Capital Corp

Fiera Capital Corp reduced its position in shares of Danaher Co. (NYSE:DHR) by 4.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 170,117 shares of the conglomerate’s stock after selling 7,781 shares during the period. Fiera Capital Corp’s holdings in Danaher were worth $39,050,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at approximately $27,000. Decker Retirement Planning Inc. acquired a new position in Danaher during the 4th quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new position in Danaher during the 4th quarter worth $31,000. Teachers Insurance & Annuity Association of America acquired a new stake in Danaher in the third quarter worth $39,000. Finally, MidAtlantic Capital Management Inc. bought a new stake in Danaher in the third quarter valued at $40,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. Stifel Nicolaus upped their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Guggenheim began coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price for the company. JPMorgan Chase & Co. reduced their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research report on Friday, December 13th. Finally, Citigroup reduced their price target on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of NYSE:DHR opened at $203.56 on Friday. The company has a market capitalization of $147.03 billion, a PE ratio of 38.55, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a fifty day moving average of $230.49 and a 200-day moving average of $250.28. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business posted $2.09 earnings per share. As a group, equities analysts anticipate that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.53%. Danaher’s dividend payout ratio is currently 20.45%.

Insider Buying and Selling

In other news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.